News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.
RECOVER researchers examined more than 2.2 million Americans' health data to learn why some people are more likely to develop Long COVID.
During the May 9th RECOVER Research Review (R3) Seminar, researchers from PEDSnet presented RECOVER research about PASC in children and adolescents using EHR data. The panelists discussed the clinical features and burden of pediatric PASC and explained how research findings could be used to develop a definition of long COVID in children.
During the April 25th RECOVER Research Review (R3) Seminar, researchers presented the status of RECOVER clinical trial protocols. Presenters discussed the landscape of Long COVID's clinical trials and the development of RECOVER's upcoming clinical trials.
During the April 11th RECOVER Research Review (R3) Seminar, researchers explored the mechanistic pathways of PASC, focusing on how the virus that causes COVID-19 led to long-term effects. Presenters discussed the molecular basis of Long COVID, including olfactory impairment, plasma proteomics, and the role of T-cell chronotypes in autoimmunity.
During the March 14th RECOVER Research Review (R3) Seminar, researchers presented on how to characterize PASC in adults using electronic health record (EHR) data. The seminar covered the RECOVER EHR cohort study, the National COVID Cohort Collaborative (N3C), and two different methods to identify PASC subphenotypes based on symptom presentation.
Three leaders at the NIH explain how patient experiences have guided and will continue to guide RECOVER's efforts to understand, diagnose, prevent, and treat Long COVID.